Lin Cui, Chen Jihua, Hu Minmin, Zheng Wenya, Song Ziyu, Qin Hong
Department of Nutrition Science and Food Hygiene, Xiangya School of Public Health, Central South University, Changsha, Hunan, China.
Food Nutr Res. 2021 May 10;65. doi: 10.29219/fnr.v65.7577. eCollection 2021.
Obesity is defined as an imbalance between energy intake and expenditure, and it is a serious risk factor of non-communicable diseases. Recently many studies have shown that promoting browning of white adipose tissue (WAT) to increase energy consumption has a great therapeutic potential for obesity. Sesamol, a lignan from sesame oil, had shown potential beneficial functions on obesity treatment.
In this study, we used C57BL/6J mice and 3T3-L1 adipocytes to investigate the effects and the fundamental mechanisms of sesamol in enhancing the browning of white adipocytes to ameliorate obesity.
Sixteen-week-old C57BL/6J male mice were fed high-fat diet (HFD) for 8 weeks to establish the obesity models. Half of the obese mice were administered with sesamol (100 mg/kg body weight [b.w.]/day [d] by gavage for another 8 weeks. Triacylglycerol (TG) and total cholesterol assay kits were used to quantify serum TG and total cholesterol (TC). Oil red O staining was used to detect lipid droplet . Mito-Tracker Green was used to detect the mitochondrial content. Quantitative reverse transcription-polymerase chain reaction (RT-PCR) was used to detect the levels of beige-specific genes. Immunoblotting was used to detect the proteins involved in beige adipocytes formation.
Sesamol decreased the content of body fat and suppressed lipid accumulation in HFD-induced obese mice. In addition, sesamol significantly upregulated uncoupling protein-1 (UCP1) protein in adipose tissue. Further research found that sesamol also significantly activated the browning program in mature 3T3-L1 adipocytes, manifested by the increase in beige-specific genes and proteins. Moreover, sesamol greatly increased mitochondrial biogenesis, as proved by the upregulated protein levels of mitochondrial biogenesis, and the inhibition of the proteins associated with mitophagy. Furthermore, β3-adrenergic receptor (β3-AR), protein kinase A-C (PKA-C) and Phospho-protein kinase A (p-PKA) substrate were elevated by sesamol, and these effects were abolished by the pretreatment of antagonists β3-AR.
Sesamol promoted browning of white adipocytes by inducing mitochondrial biogenesis and inhibiting mitophagy through the β3-AR/PKA pathway. This preclinical data promised the potential to consider sesamol as a metabolic modulator of HFD-induced obesity.
肥胖被定义为能量摄入与消耗之间的失衡,是一种严重的非传染性疾病风险因素。最近许多研究表明,促进白色脂肪组织(WAT)褐变以增加能量消耗对肥胖具有巨大的治疗潜力。芝麻酚是芝麻油中的一种木脂素,已显示出对肥胖治疗的潜在有益作用。
在本研究中,我们使用C57BL/6J小鼠和3T3-L1脂肪细胞来研究芝麻酚增强白色脂肪细胞褐变以改善肥胖的作用及其基本机制。
16周龄的C57BL/6J雄性小鼠喂食高脂饮食(HFD)8周以建立肥胖模型。将一半肥胖小鼠通过灌胃给予芝麻酚(100mg/kg体重[b.w.]/天[d]),持续8周。使用甘油三酯(TG)和总胆固醇检测试剂盒定量血清TG和总胆固醇(TC)。油红O染色用于检测脂滴。Mito-Tracker Green用于检测线粒体含量。定量逆转录聚合酶链反应(RT-PCR)用于检测米色特异性基因的水平。免疫印迹用于检测参与米色脂肪细胞形成的蛋白质。
芝麻酚降低了高脂饮食诱导的肥胖小鼠的体脂含量并抑制了脂质积累。此外,芝麻酚显著上调了脂肪组织中解偶联蛋白-1(UCP1)的蛋白水平。进一步研究发现,芝麻酚还显著激活了成熟3T3-L1脂肪细胞中的褐变程序,表现为米色特异性基因和蛋白质的增加。此外,芝麻酚极大地增加了线粒体生物发生,这通过线粒体生物发生蛋白水平的上调以及与线粒体自噬相关蛋白的抑制得到证明。此外,芝麻酚使β3-肾上腺素能受体(β3-AR)、蛋白激酶A-C(PKA-C)和磷酸化蛋白激酶A(p-PKA)底物升高,而β3-AR拮抗剂预处理可消除这些作用。
芝麻酚通过诱导线粒体生物发生并通过β3-AR/PKA途径抑制线粒体自噬来促进白色脂肪细胞褐变。该临床前数据表明芝麻酚有潜力被视为高脂饮食诱导肥胖的代谢调节剂。